Let’s Get Social: The Ascendancy of Social Media to the Top of the Media Mix
January 19th 2023Fran Pollaro talks with Amanda Powers-Han, chief marketing officer at Greater Than One, a full-experience marketing agency dedicated to healthcare, about what’s trending in early 2023 for pharma media mixes.
Leadership in the US vs. Europe and Launching a Rare Disease Drug
November 10th 2022In episode 121, Nathalie Dompé, co-CEO of Dompé Pharmaceuticals, shares a glimpse into her journey in the pharma industry, her leadership style, the differences in working in leadership in the United States vs. Europe (Italy, specifically), and technologies in the biopharma industry.
An Invitation to Define the Lab of the Future
November 10th 2022Today’s labs are not sufficient to handle tomorrow’s challenges. What will labs in 2030 or 2040 look like? Mikael Hagstroem, CEO at LabVantage Solutions and expert in harnessing data and analytics, discusses the three phases of digital transformation needed to reimagine business models, achieve better performance, and create long-term sustainable advantage. It starts with changing our labs – the technologies, processes, ways of working, and data solutions.
Behind the Creative…..Inspiring Award Winning Creative with Sarah McKinnon
October 26th 2022Sarah McKinnon, Senior Art Director at The Grey Group, discusses her entrance into the advertising world through blending art and science in school, understanding the connection between human health and storytelling, her own experiences as a patient along with a healthy dose of grit and passion¾to inform her audiences and her career.
Accelerating New Medicines: Innovation and Technology at Curia
October 25th 2022Curia is proud to partner with pharma and biotech companies to make new medicines that save lives. In order to be able to do that, Curia needs to be constantly innovating. In this podcast, you will learn from Curia’s VP of Portfolio and Sourcing, James Grabowski, about Curia’s small and large molecules most recent technologies, and capabilities.
How AI and Real World Data are Reshaping Medical Affairs
October 18th 2022Real world data (RWD) and artificial intelligence (AI) offer an unprecedented opportunity for Medical Affairs professionals to gather and share deeper insights about patients, including insights regarding disease progression, outcomes, and treatment response, as well as additional insights about patients’ journeys prior to diagnosis and after treatment initiation. Cindy Weber, of IQVIA’s Artificial Intelligent Solutions team explains how embracing RWD and technology, and the opportunities they provide, is helping to transform Medical Affairs and is enabling professionals to create better, more meaningful, connections with healthcare professionals; thereby helping to improve patient care.
Beyond Static Reports – Dynamic Dashboards for Patient-Level Insights
October 18th 2022In the past, patient-level insights were achieved through time-consuming methods requiring substantial manual effort to produce static reports. With the help of technology and machine learning, that’s no longer the case. Join Andy Burch and Brian Smith, two thought leaders with a breadth of experience in AI-ML solutions, as they dive into the benefits of bringing automated data in to dynamic visualization products and how they can help you achieve instant insights.
From Persia To Precision Medicine
September 15th 2022In episode 117, Helen Sabzevari, CEO of Precigen, discusses her drive to study science as a Persian-born woman, the opportunities she’s had to research immunology, and how she’s now developing next-generation CAR-T treatments for cancer, in addition to other therapies.
Behind the Creative….Inspiring Award Winning Creative with Halen Dang and Carrie Morris
August 9th 2022Proximyl Health’s Halen Dang, VP, Creative Director of Art and Carrie Morris, VP, Creative Director of Copy discuss remote teamwork and how to successfully lead agency creative teams with hybrid schedules.
Biometrics and AI Technologies in Cancer Treatment
July 29th 2022The use of biometric data and novel digital biomarkers in the administration of CAR-T therapy can both improve the safety profile and reduce patient burden of cancer treatment. Jaydev Thakkar, Chief Operating Officer at Biofourmis, will share how this data paired with FDA-cleared algorithms can predict the onset of adverse events to allow for proactive intervention and improved patient outcomes.
Behind the Creative…Inspiring Award Winning Creative Carolyn O’Neill
July 19th 2022Carolyn O’Neill, Chief Creative Officer of Centron discusses their APEX-award winning global disease awareness campaign for both HCPs and patients, “Dimensionalizing the Patient Experience in PNH.” PNH or paroxysmal nocturnal hemoglobinuria is a rare immune disorder that attacks a person’s red blood cells. The campaign was meant to build on it is not an inherited disease and people’s symptoms don’t exhibit externally, usually appearing in mid-life and portray the feelings of a PNH sufferer.
Behind the Creative…Inspiring Award Winning Creative with Omair Ahmed
June 29th 2022Nexus Pharmaceuticals' Chief Strategy Officer Omair Ahmed discusses their APEX-award winning EMERPHED™ campaign, which built on the ideas of simplification, safety and stability to enhance their hospital-delivered product and support their field sales reps.
Behind the Creative…Inspiring Award Winning Creative with John England
June 8th 2022CDM Princeton’s Senior Creative Vice President John England discuss the company’s APEX-award winning Ilumya campaign “Defy the Laws of Psoriasis,” which used multiple innovative ideas including an AR focused in-person interactive piece, a upward scrolling website and more.